Richard Hughes is a multi-talented health lawyer, strategic advisor, advocate, and teacher.

His thought leadership and problem-solving strategies have broken barriers to access for vaccines and medicines. His advice on legal and policy solutions is sought after by leading biopharmaceutical companies, industry trade associations, investors, patient advocacy organizations, members of Congress and Congressional committees, and federal agencies.

Richard's practice emphasizes vaccines, prevention, and early intervention. Health care and life sciences clients value his guidance and counsel on legal, regulatory, and policy issues, as well as his ability to assemble multidisciplinary consulting teams to offer strategic business advice and build market development strategies.

Read more

Previously, Richard served as Managing Director at a leading Washington health care advisory firm and Vice President at a major vaccine manufacturer during the COVID-19 pandemic.

Before becoming an attorney, Richard served in several health policy leadership roles. He was a gubernatorial appointee to the Arkansas State Board of Health, where he deliberated regulatory policy, presided over appeals before the state health department, and advocated for vaccine access. Richard has also held roles at the Association of State and Territorial Health Officials and with another leading biopharmaceutical company.

Outside of his practice, Richard devotes his time to teaching and mentoring students. He is a Professorial Lecturer in Law at The George Washington University Law School and previously served as a Professorial Lecturer in Health Policy & Management at the Milken Institute School of Public Health.

He publishes regularly in health law and policy journals, frequently writes commentary on Health Affairs Forefront, and is often quoted in the news media, including The New York Times, The Washington Post, NPR's Marketplace, The Hill, Forbes, Axios, Bloomberg Law, Law360, and Fierce Healthcare.

Read less

Focus Areas


  • Delta Omega Honorary Society in Public Health
  • Health Affairs, Top 10 Most-Read Health Affairs Blog Posts of 2019 (No. 9) (2019)
  • University of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health, Center Stage Alumni (2021)



  • The George Washington University Law School (J.D.)
    • Health Law
  • University of Arkansas for Medical Sciences (M.P.H.)
  • Arkansas State University (B.S.)

Professional & Community Involvement

  • American Bar Association, Health Law Section
  • American Health Lawyers Association
  • American Journal of Public Health, Peer-Reviewer
  • American Public Health Association
  • American Society of Law, Medicine, and Ethics
  • Arkansas State Board of Health (Gubernatorial Appointment) (2006 to 2009)
  • National Vaccine Law Conference, Steering Committee





Public Policy Strategy

  • Develops federal and state policy strategies for vaccine and other biopharmaceutical manufacturers, and advises clients on strategies for engaging state and federal agencies, including FDA, CDC, CMS, and BARDA.

Business Advisor

  • Counsels investors and startups on market trends and developments in health care, including identifying total addressable markets. Richard also facilitates multidisciplinary expert input and advisory boards for clients.

Product Launch Advice

  • Advises multiple manufacturers on launch strategy for new vaccines and other products.
  • Advises novel, non-vaccine developers on strategies for obtaining a “vaccine-like” recommendation, coverage, and reimbursement pathway.

Thought Leadership

  • Influences public policy development as a thought leader in the field of preventive health care and public health. Richard advised or engaged the White House, HHS, CDC, HHS, and Congressional offices on the development of vaccine policy.

Research and Analysis

  • Conducted many 50-state analyses of laws, regulations, and Medicaid coverage policies, as well as payor coverage analyses. Richard led studies using survey methods and claims-based analyses of vaccine-preventable disease burden and uptake in Medicare and other markets.
Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.